A detailed history of Ars Wealth Advisors Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ars Wealth Advisors Group, LLC holds 2,086 shares of LLY stock, worth $1.56 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
2,086
Previous 2,066 0.97%
Holding current value
$1.56 Million
Previous $1.87 Million 1.18%
% of portfolio
0.23%
Previous 0.24%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$772.14 - $960.02 $15,442 - $19,200
20 Added 0.97%
2,086 $1.85 Million
Q2 2024

Jul 19, 2024

BUY
$724.87 - $909.04 $31,894 - $39,997
44 Added 2.18%
2,066 $1.87 Million
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $11,251 - $15,053
-19 Reduced 0.93%
2,022 $1.57 Million
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $65,123 - $76,772
124 Added 6.47%
2,041 $1.19 Million
Q3 2023

Oct 26, 2023

BUY
$434.7 - $599.3 $38,688 - $53,337
89 Added 4.87%
1,917 $1.03 Million
Q2 2023

Jul 18, 2023

SELL
$350.74 - $468.98 $131,527 - $175,867
-375 Reduced 17.02%
1,828 $857,000
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $114,933 - $134,983
370 Added 20.19%
2,203 $756,000
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $1.74 Million - $2.02 Million
-5,401 Reduced 74.66%
1,833 $670,000
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $2.14 Million - $2.44 Million
7,234 New
7,234 $2.34 Million
Q3 2022

Nov 08, 2022

SELL
$296.48 - $337.87 $2.14 Million - $2.44 Million
-7,234 Closed
0 $2.34 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $185,912 - $218,289
667 Added 10.16%
7,234 $2.35 Million
Q1 2022

May 12, 2022

SELL
$234.69 - $291.66 $15,020 - $18,666
-64 Reduced 0.97%
6,567 $1.88 Million
Q4 2021

Feb 08, 2022

BUY
$224.85 - $279.04 $22,709 - $28,183
101 Added 1.55%
6,631 $1.83 Million
Q3 2021

Oct 26, 2021

BUY
$221.6 - $272.71 $1.45 Million - $1.78 Million
6,530 New
6,530 $1.51 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ars Wealth Advisors Group, LLC Portfolio

Follow Ars Wealth Advisors Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ars Wealth Advisors Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ars Wealth Advisors Group, LLC with notifications on news.